Literature DB >> 6702035

Squamous cell carcinoma of bladder.

A J Costello, R C Tiptaft, H R England, J P Blandy.   

Abstract

Examination of the histology of all bladder tumors presented to the London Hospital over a ten-year period revealed a surprisingly low incidence of squamous bladder carcinoma. We would support the view of other workers that this tumor usually presents at an advanced stage and carries with it a poor prognosis. However, when no evidence of metastatic disease is evident, treatment with standard protocol of radiation therapy and cystectomy should achieve the same results as for the transitional cell tumor. Squamous cell carcinoma of the bladder would appear to be as radiosensitive as its transitional cell counterpart.

Entities:  

Mesh:

Year:  1984        PMID: 6702035

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Aetiological factors of bladder cancer in the Aegean region of Turkey between the years 1985-1996.

Authors:  B Gümüş; O Aras; Y Z Ateşçi; T Müezzinoğlu
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

2.  Urinary bladder cancer in yemen.

Authors:  Abdullah Saleh Al-Samawi; Saleh Mansoor Aulaqi
Journal:  Oman Med J       Date:  2013-09

Review 3.  [Squamous cell lesions of the urinary bladder].

Authors:  S Rausch; N Gaisa; R F Youssef; Y Lotan; A Stenzl; T Kälble
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

4.  BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.

Authors:  Gareth O Griffiths; Richard A Cowan; Kenneth M Grigor; Barbara M Uscinska; Matthew Sydes; Martin Russell
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.